Form 4: agilon health Chief Markets Officer Tax Withholding
Statement of Changes in Beneficial Ownership
Benjamin Shaker, Chief Markets Officer of agilon health, inc., reported the withholding of 675 shares to satisfy tax obligations.
Summary
- Benjamin Shaker, Chief Markets Officer at agilon health, inc., executed a net settlement of restricted stock units.
- A total of 104 shares were withheld on 04/14/2026 at a price of $22.68 per share.
- A total of 571 shares were withheld on 04/15/2026 at a price of $26.88 per share.
- These transactions were for tax withholding purposes and do not represent open-market sales.
- Following these transactions, the reporting person holds 122,850 shares of common stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine administrative action regarding executive compensation rather than a strategic or operational shift.
Positives
- The transaction reflects the vesting of equity compensation, indicating alignment between executive incentives and company performance.
Negatives
- None identified; this is a routine administrative transaction related to tax obligations.
Risks
- None identified; this is a standard regulatory disclosure for executive equity management.
Future Outlook
Not applicable; this is a retrospective disclosure of an equity transaction.
Industry Context
StockSavvy.ai notes that routine tax withholding filings by executives are standard industry practice and do not typically signal changes in management sentiment or company outlook.
Comparison to Industry Standards
- The transaction follows standard SEC reporting requirements for executive equity compensation.
- Net settlement of restricted stock units is a common practice among publicly traded healthcare and technology firms.
Stakeholder Impact
- No material impact on shareholders, employees, or other stakeholders.
Key Dates
| Date | Description |
|---|---|
| 04/14/2026 | Date of first tax withholding transaction. |
| 04/15/2026 | Date of second tax withholding transaction. |
| 04/16/2026 | Date of filing. |
Keywords
agilon health, AGL, Form 4, insider transaction, tax withholding, equity compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.